Stockholders' Deficit (Details Textual)	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 29, 2020 shares	Jun. 30, 2020 USD ($) $ / shares shares	Jun. 30, 2019 USD ($) consultant	Jun. 30, 2020 USD ($) $ / shares shares	Jun. 30, 2019 USD ($) consultant $ / shares shares	Dec. 31, 2018	Dec. 31, 2016	Dec. 31, 2019 $ / shares shares
Common stock, shares authorized | shares		50,000,000		50,000,000				50,000,000
Common stock, par value | $ / shares		$ 0.00001		$ 0.00001				$ 0.00001
Stock-based compensation				$ 213,332
Settlement of payables and accrued liabilities		$ 457,096		457,096
Stock-based compensation				2,466,312	$ 910,548
Stock option expense		26,161	$ 297,862	278,233	517,032
Recognized stock-based compensation				$ 255,717
Stock-based compensation expenses, description				Stock-based compensation related to restricted stock units for the three and six months ended June 30, 2020 was $121,797 and $284,897, respectively. As of June 30, 2020, unrecognized compensation expense related to the unvested restricted stock units is $620,821 and is expected to be recognized over approximately 1.9 years.
Unvested restricted stock expense		$ 121,797	$ 67,680	$ 284,897	$ 102,191
Acquisition of stock, description						The 2018 Plan provides for the grant of equity awards to purchase shares of common stock. Up to 3,000,000 shares of common stock may be issued pursuant to awards granted under the 2018 Plan, subject to increases that occur starting in 2021. The 2018 Plan is administered by the Board of Directors, and expires ten years after adoption, unless terminated earlier by the Board.	The 2016 Plan provides for the grant of equity awards to highly qualified personnel, including stock options, restricted stock, stock appreciation rights, and restricted stock units to purchase shares of common stock. Up to 2,227,777 shares of common stock may be issued pursuant to awards granted under the 2016 Plan. The 2016 Plan is administered by the Board of Directors, and expires ten years after adoption, unless terminated earlier by the Board.
Granted restricted stock units vest | shares				100,000
Description of restricted stock					the Company granted 165,000 restricted stock units, respectively, to employees of the Company that generally vest between one and four years. Stock-based compensation related to restricted stock units for the three and six months ended June 30, 2019 was $67,680 and $102,191, respectively.
Granted common shares | shares				78,431
Warrants exercised for cash					$ 873,403
Weighted average period				8 months 12 days
Unvested stock options				$ 44,720
Legal and Consulting Services [Member]
Legal and other fees					263,825
Fair value of options granted					$ 527,650
Number of shares, Granted | shares				314,535
Granted common shares | shares					105,000
Number of service providers | consultant			2		2
Consulting Services [Member]
Common stock shares issued | shares					10,000
Shares of restricted common stock | shares					400,000
Stock-based compensation				$ 27,500
Forfeitable restricted stock shares | shares				400,000
Number of consultant | consultant			1		1
Common Stock
Common stock, shares authorized | shares		50,000,000		50,000,000
Common stock, par value | $ / shares		$ 0.00001		$ 0.00001
Stock option expense
Unvested restricted stock expense
Warrants exercised for cash, shares | shares					274,224
Warrants exercised for cash					$ 3
Stock Options [Member]
Stock option expire term					10 years
Option vested year					4 years
Stock-based compensation		$ 26,161	$ 297,862	$ 278,233	$ 517,032
Fair value of options granted					$ 1,946,281
Stock options forfeited | shares	1,487,500
Number of shares, Granted | shares					1,050,000
Stock-based compensation expenses, description				The total estimated remaining stock-based compensation expense for unvested stock options is approximately $44,720 which is expected to be recognized over a weighted average period of 0.7 years.
Granted common shares | shares	822,500			1,434,132
Stock options exercise price upper maximum | $ / shares					$ 5.53
Stock options exercise price lower minimum | $ / shares					$ 3.20